REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- EBITDA, 2025
- $4.1B
- YoY, 2025
- −7.9%
- 5-year CAGR
- +1.6%
- 10-year CAGR
- +12.0%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $4.1B | −7.9% |
| 2024 | $4.5B | +0.1% |
| 2023 | $4.5B | −12.1% |
| 2022 | $5.1B | −45.0% |
| 2021 | $9.2B | +142.2% |
| 2020 | $3.8B | +57.5% |
| 2019 | $2.4B | −9.8% |
| 2018 | $2.7B | +20.6% |
| 2017 | $2.2B | +55.0% |
| 2016 | $1.4B | +8.2% |
| 2015 | $1.3B | +51.4% |
| 2014 | $877M | +11.8% |
| 2013 | $784M | +58.5% |
| 2012 | $495M | — |
| 2011 | −$174M | — |
| 2010 | −$78M | — |
| 2009 | −$60M | — |
| 2008 | −$75M | — |